Cargando…

Latent tuberculosis and the use of immunomodulatory agents

Detalles Bibliográficos
Autores principales:	Aguiar, Fábio Silva, Mello, Fernanda Carvalho de Queiroz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447547/ https://www.ncbi.nlm.nih.gov/pubmed/31826106 http://dx.doi.org/10.1590/1806-3713/e20190361

Ejemplares similares

Tuberculosis series 2019
por: Silva, Denise Rossato, et al.
Publicado: (2019)

Tuberculosis: where are we?
por: Mello, Fernanda Carvalho de Queiroz, et al.
Publicado: (2018)

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Tuberculosis Series 2021
por: Silva, Denise Rossato, et al.
Publicado: (2021)

“Post-tuberculosis financial disease”-we need to face it to eliminate tuberculosis
por: Santos, Ana Paula, et al.
Publicado: (2023)

Diagnosis and management of post-tuberculosis lung disease
por: Silva, Denise Rossato, et al.
Publicado: (2023)

In the time of strategies to end tuberculosis, prevention is better than treatment
por: Santos, Ana Paula, et al.
Publicado: (2020)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Tuberculosis series
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Latent tuberculosis infection in patients with rheumatic diseases
por: Anton, Camila, et al.
Publicado: (2019)

The role of the Brazilian Tuberculosis Research Network in national and international efforts to eliminate tuberculosis
por: Kritski, Afranio, et al.
Publicado: (2018)

Immunomodulatory Agents for Multiple Myeloma
por: Minařík, Jiří, et al.
Publicado: (2022)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Latent tuberculosis infection and kidney transplantation
por: Tuon, Felipe Francisco
Publicado: (2021)

Nursing professionals’ leading role in expanding the treatment for latent Mycobacterium tuberculosis infection in Brazil
por: Johansen, Fernanda Dockhorn Costa, et al.
Publicado: (2023)

Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection
por: de Araujo, Leonardo Silva, et al.
Publicado: (2019)

Screening for latent tuberculosis: the way forward for tuberculosis elimination
por: Petersen, Eskild, et al.
Publicado: (2022)

New Diagnostics to Infer Risk in Tuberculosis: Is the Term “Latent Tuberculosis Infection” Obsolete?
por: Escalante, Patricio, et al.
Publicado: (2021)

Management of latent tuberculosis infection: An evidence-based approach
por: Pai, Madhukar, et al.
Publicado: (2015)

Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
por: Vernon, Andrew, et al.
Publicado: (2020)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

It's Time for Latent Tuberculosis Infection Screening in HIV-infected Individuals
por: Park, Chan Kwon, et al.
Publicado: (2019)

Potential immunomodulatory effects of latent toxoplasmosis in humans
por: Flegr, Jaroslav, et al.
Publicado: (2011)

Latent Tuberculosis Infection–associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
por: Dheda, Keertan, et al.
Publicado: (2020)

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity
por: Rao Muvva, Jagadeeswara, et al.
Publicado: (2021)

The diagnosis and treatment of latent tuberculosis by nurses in Brazil: a necessary strategy
por: Arcêncio, Ricardo Alexandre, et al.
Publicado: (2022)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

Synthesis and Biological Activity of Antimicrobial Agents
por: Carvalho, M. Fernanda N. N.
Publicado: (2022)

Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Prevalence of latent Mycobacterium tuberculosis infection in prisoners
por: de Navarro, Pedro Daibert, et al.
Publicado: (2016)

Phytochemicals as Immunomodulatory Agents in Melanoma
por: Tabolacci, Claudio, et al.
Publicado: (2023)

Successful transition to the QFT-PLUS assay, but more is needed for diagnosis of latent tuberculosis infection
por: Lee, Eun Hye, et al.
Publicado: (2020)

COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology
por: Değirmenci, Mehmet Fatih Kağan, et al.
Publicado: (2021)

Estimated rates of recurrence, cure, and treatment abandonment in patients with pulmonary tuberculosis treated with a four-drug fixed-dose combination regimen at a tertiary health care facility in the city of Rio de Janeiro, Brazil
por: da Silva, Vangie Dias, et al.
Publicado: (2017)

Latent tuberculosis
por: Koul, Ajaz Nabi
Publicado: (2016)

Yield of close contact tracing using two different programmatic approaches from tuberculosis index cases: a retrospective quasi-experimental study
por: Loredo, Carla, et al.
Publicado: (2014)

Immunomodulatory biomaterials and regenerative immunology
por: Vrana, Nihal Engin
Publicado: (2016)

Synthesis and Biological Activity of Antimicrobial Agents, 2nd Volume
por: Carvalho, Maria Fernanda N. N.
Publicado: (2023)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Tuberculosis Infection and Latent Tuberculosis
por: Lee, Seung Heon
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4mp4kk4bh99b3kh29vcvicp9i6